<?xml version="1.0" encoding="UTF-8"?>
<p>Mendelian randomization (MR) is a powerful method to investigate the interplay between genetic and environmental disease risks, enabling a more robust understanding of pathogenesis. MR has recently gathered considerable traction in neurodegenerative disease research, and this review aims to evaluate the impact of MR studies on translational medicine for these conditions. We will</p>
